Cargando…
Haematological malignancies in relatives of patients affected with myeloproliferative neoplasms
In a cohort of 3131 patients with myeloproliferative neoplasms (MPNs), we identified 200 patients (6.4%) who reported a second case of haematological malignancies (HM) in first‐ or second‐degree relatives. The occurrence of a second HM in the family was not influenced by MPN subtype, sex or driver m...
Autores principales: | Vanni, Daniele, Borsani, Oscar, Nannya, Yasuhito, Sant'Antonio, Emanuela, Trotti, Chiara, Casetti, Ilaria Carola, Pietra, Daniela, Gallì, Anna, Zibellini, Silvia, Ferretti, Virginia Valeria, Malcovati, Luca, Ogawa, Seishi, Arcaini, Luca, Rumi, Elisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176120/ https://www.ncbi.nlm.nih.gov/pubmed/35846061 http://dx.doi.org/10.1002/jha2.425 |
Ejemplares similares
-
Autoantibodies Against Type I IFNs in Patients with Ph-Negative Myeloproliferative Neoplasms
por: Borsani, Oscar, et al.
Publicado: (2021) -
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms
por: Borsani, Oscar, et al.
Publicado: (2022) -
Risk of Thrombosis in Myeloproliferative Neoplasms after Sars-Cov-2 Vaccination
por: Borsani, Oscar, et al.
Publicado: (2022) -
SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms
por: Borsani, Oscar, et al.
Publicado: (2023) -
P984: MUTATIONAL PATTERNS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS (MPN)
por: Casetti, I. C., et al.
Publicado: (2022)